Six‐month BNT162b2 vaccine efficacy in adolescents and young adults with cancer

Caroline Donze; Laetitia Ninove; Xavier Lamballerie; Paul Saultier; Nicolas André

doi:10.1002/pbc.29547

Journal Articles Pediatric Blood and Cancer Year : 2022

Six‐month BNT162b2 vaccine efficacy in adolescents and young adults with cancer

, , , , (1)

1

Caroline Donze

Function : Author

Laetitia Ninove

Function : Author

Xavier Lamballerie

Function : Author

Paul Saultier

Function : Author
PersonId : 780499
ORCID : 0000-0002-6327-0898

Nicolas André

Function : Author
PersonId : 907890

Centre de Recherche en Cancérologie de Marseille

Domains

Life Sciences [q-bio] Cancer

Nicolas André : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03625352

Submitted on : Wednesday, March 30, 2022-6:30:59 PM

Last modification on : Thursday, March 31, 2022-4:08:51 AM

Dates and versions

hal-03625352 , version 1 (30-03-2022)

Identifiers

HAL Id : hal-03625352 , version 1
DOI : 10.1002/pbc.29547

Cite

Caroline Donze, Laetitia Ninove, Xavier Lamballerie, Paul Saultier, Nicolas André. Six‐month BNT162b2 vaccine efficacy in adolescents and young adults with cancer. Pediatric Blood and Cancer, In press, ⟨10.1002/pbc.29547⟩. ⟨hal-03625352⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU CRCM

6 View

0 Download

Six‐month BNT162b2 vaccine efficacy in adolescents and young adults with cancer

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share